Invention Grant
US08211426B2 ACE2 activation for treatment of heart, lung and kidney disease and hypertension
有权
ACE2激活治疗心脏，肺和肾脏疾病和高血压
- Patent Title: ACE2 activation for treatment of heart, lung and kidney disease and hypertension
- Patent Title (中): ACE2激活治疗心脏，肺和肾脏疾病和高血压
-
Application No.: US12830782Application Date: 2010-07-06
-
Publication No.: US08211426B2Publication Date: 2012-07-03
- Inventor: Joseph M. Penninger , Michael A. Crackower
- Applicant: Joseph M. Penninger , Michael A. Crackower
- Applicant Address: AT Vienna
- Assignee: Apeiron Biologics AG
- Current Assignee: Apeiron Biologics AG
- Current Assignee Address: AT Vienna
- Agency: Fulbright & Jaworski LLP
- Main IPC: A61K38/43
- IPC: A61K38/43
Abstract:
ACE2 activating compounds for prevention and treatment of cardiovascular disease, kidney disease, lung disease and hypertension are disclosed. Also disclosed are methods of diagnosing cardiovascular disease, kidney disease, lung disease and hypertension by measuring ACE2 expression or nucleotide polymorphism analysis.
Public/Granted literature
- US20100311822A1 ACE2 Activation For Treatment Of Heart, Lung and Kidney Disease and Hypertension Public/Granted day:2010-12-09
Information query
IPC分类:
